CALCIUM BLOCKERS AND BETA-BLOCKERS - ALONE AND IN COMBINATION

被引:0
|
作者
RAFTERY, EB
机构
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:188 / 196
页数:9
相关论文
共 50 条
  • [1] BETA-BLOCKERS VERSUS CALCIUM BLOCKERS
    WITCHITZ, S
    GUERMONPREZ, JL
    COEUR, 1984, 15 (02): : 193 - 195
  • [2] CALCIUM-ANTAGONISTS AND BETA-BLOCKERS IN COMBINATION
    CAIN, ME
    MARTIN, TC
    SOBEL, BE
    JOURNAL OF CARDIOVASCULAR MEDICINE, 1983, 8 (04): : 485 - &
  • [3] Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia
    Rosso, Rafael
    Kalman, Jonathan M.
    Rogowski, Ori
    Diamant, Shmuel
    Birger, Amir
    Biner, Simon
    Belhassen, Bernard
    Viskin, Sami
    HEART RHYTHM, 2007, 4 (09) : 1149 - 1154
  • [5] BETA-BLOCKERS OR CALCIUM CHANNEL BLOCKERS IN HYPERTROPHIC CARDIOMYOPATHY
    Pinto, Giuseppe
    Chiarito, Mauro
    Bacher, Anne
    Puscas, Tania
    Condorelli, Gianluigi
    Reant, Patricia
    Donal, Erwan
    Hagege, Albert
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [6] Beta-Blockers Inferior to Calcium Channel Blockers in Hypertrophic Cardiomyopathy
    Gombar, Saurabh
    Moneghetti, Kegan J.
    Callahan, Alison
    Jung, Ken
    Wheeler, Matthew T.
    CIRCULATION, 2017, 136
  • [7] Essential tremor, beta-blockers, and calcium channel blockers REPLY
    Abboud, Hesham
    Ahmed, Anwar
    Fernandez, Hubert H.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2012, 79 (04) : 242 - 242
  • [8] Beta-Blockers and Calcium Channel Blockers: First Line Agents
    Isaac Pascual
    Cesar Moris
    Pablo Avanzas
    Cardiovascular Drugs and Therapy, 2016, 30 : 357 - 365
  • [9] Calcium channel blockers, beta-blockers, and perioperative cardiovascular stability
    Biccard, B. M.
    Howell, S. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2008, 101 (04) : 439 - 441
  • [10] Beta-Blockers and Calcium Channel Blockers: First Line Agents
    Pascual, Isaac
    Moris, Cesar
    Avanzas, Pablo
    CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (04) : 357 - 365